Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.
Pastorczak A, Fendler W, Zalewska-Szewczyk B, Górniak P, Lejman M, Trelińska J, Walenciak J, Kowalczyk J, Szczepanski T, Mlynarski W; Polish Pediatric Leukemia/Lymphoma Study Group. Pastorczak A, et al. Among authors: gorniak p. Leuk Res. 2014 Feb;38(2):180-3. doi: 10.1016/j.leukres.2013.10.027. Epub 2013 Nov 5. Leuk Res. 2014. PMID: 24268318
Role of 657del5 NBN mutation and 7p12.2 (IKZF1), 9p21 (CDKN2A), 10q21.2 (ARID5B) and 14q11.2 (CEBPE) variation and risk of childhood ALL in the Polish population.
Pastorczak A, Górniak P, Sherborne A, Hosking F, Trelińska J, Lejman M, Szczepański T, Borowiec M, Fendler W, Kowalczyk J, Houlston RS, Młynarski W. Pastorczak A, et al. Among authors: gorniak p. Leuk Res. 2011 Nov;35(11):1534-6. doi: 10.1016/j.leukres.2011.07.034. Epub 2011 Sep 1. Leuk Res. 2011. PMID: 21889209
Polymorphism in IKZF1 gene affects age at onset of childhood acute lymphoblastic leukemia.
Górniak P, Pastorczak A, Zalewska-Szewczyk B, Lejman M, Trelińska J, Chmielewska M, Sokół-Jeżewska A, Kowalczyk J, Szczepanski T, Matysiak M, Kazanowska B, Mlynarski W; Polish Pediatric Leukemia/Lymphoma Study Group. Górniak P, et al. Leuk Lymphoma. 2014 Sep;55(9):2174-8. doi: 10.3109/10428194.2013.866661. Epub 2014 Apr 2. Leuk Lymphoma. 2014. PMID: 24597983
Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.
Pastorczak A, Sedek L, Braun M, Madzio J, Sonsala A, Twardoch M, Fendler W, Nebral K, Taha J, Bielska M, Gorniak P, Romiszewska M, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Badowska W, Niedzwiecki M, Kazanowska B, Muszynska-Roslan K, Sobol-Milejska G, Karolczyk G, Koltan A, Ociepa T, Szczepanski T, Młynarski W. Pastorczak A, et al. Among authors: gorniak p. Oncotarget. 2018 May 25;9(40):25971-25982. doi: 10.18632/oncotarget.25411. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899835 Free PMC article.
Predictive significance of selected gene mutations in relapsed and refractory chronic lymphocytic leukemia patients treated with ibrutinib.
Machnicki MM, Górniak P, Pępek M, Szymczyk A, Iskierka-Jażdżewska E, Steckiewicz P, Bluszcz A, Rydzanicz M, Hus M, Płoski R, Makuch-Łasica H, Nowak G, Juszczyński P, Jamroziak K, Stokłosa T, Puła B. Machnicki MM, et al. Among authors: gorniak p. Eur J Haematol. 2021 Mar;106(3):320-326. doi: 10.1111/ejh.13550. Epub 2020 Dec 19. Eur J Haematol. 2021. PMID: 33190294
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen.
Libura M, Bialopiotrowicz E, Giebel S, Wierzbowska A, Roboz GJ, Piatkowska-Jakubas B, Pawelczyk M, Gorniak P, Borg K, Wojtas M, Florek I, Matiakowska K, Jazwiec B, Solarska I, Noyszewska-Kania M, Piechna K, Zawada M, Czekalska S, Salamanczuk Z, Karabin K, Wasilewska K, Paluszewska M, Urbanowska E, Gajkowska-Kulik J, Semenczuk G, Rybka J, Wrobel T, Ejduk A, Kata D, Grosicki S, Robak T, Pluta A, Kominek A, Piwocka K, Pyziak K, Sroka-Porada A, Wrobel A, Przybylowicz A, Wojtaszewska M, Lewandowski K, Gil L, Piekarska A, Knopinska W, Bolkun L, Warzocha K, Kuliczkowski K, Sacha T, Basak G, Jedrzejczak WW, Holowiecki J, Juszczynski P, Haus O. Libura M, et al. Among authors: gorniak p. Sci Rep. 2021 May 11;11(1):10017. doi: 10.1038/s41598-021-88120-y. Sci Rep. 2021. PMID: 33976256 Free PMC article.
MEK Inhibition Sensitizes Precursor B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells to Dexamethasone through Modulation of mTOR Activity and Stimulation of Autophagy.
Polak A, Kiliszek P, Sewastianik T, Szydłowski M, Jabłońska E, Białopiotrowicz E, Górniak P, Markowicz S, Nowak E, Grygorowicz MA, Prochorec-Sobieszek M, Nowis D, Gołąb J, Giebel S, Lech-Marańda E, Warzocha K, Juszczyński P. Polak A, et al. Among authors: gorniak p. PLoS One. 2016 May 19;11(5):e0155893. doi: 10.1371/journal.pone.0155893. eCollection 2016. PLoS One. 2016. PMID: 27196001 Free PMC article.
Comparison of high-resolution melting analysis with direct sequencing for the detection of recurrent mutations in DNA methyltransferase 3A and isocitrate dehydrogenase 1 and 2 genes in acute myeloid leukemia patients.
Gorniak P, Ejduk A, Borg K, Makuch-Lasica H, Nowak G, Lech-Maranda E, Prochorec-Sobieszek M, Warzocha K, Juszczynski P. Gorniak P, et al. Eur J Haematol. 2016 Feb;96(2):181-7. doi: 10.1111/ejh.12566. Epub 2015 May 13. Eur J Haematol. 2016. PMID: 25891904
23 results